At a glance
This program funds rigorous, high-impact research on multiple sclerosis that could improve research, patient care, or quality of life. Applicants must address one or more FY26 focus areas, and clinical trials are not allowed. Eligible applicants include extramural and intramural U.S. Department of War organizations, as well as foreign and domestic, for-profit and nonprofit, and public or private organizations; awards are made to organizations, not individuals. The program expects to fund about six awards with roughly $6.0 million total, with a maximum of $1.0 million in total costs per award and a performance period of up to 3 years. Cost sharing is not required, and the research must be relevant to active-duty Service Members, Veterans, military beneficiaries, and/or the American public.
What it funds
Official description from grants.gov
Summary: The fiscal year 2026 (FY26) Multiple Sclerosis Research Program (MSRP) Investigator-Initiated Research Award (IIRA) supports highly rigorous, high-impact research projects that have the potential to make an important contribution to Multiple Sclerosis (MS) research, patient care, and/or quality of life. All applications must address at least one of the FY26 MSRP IIRA focus areas. Research projects may focus on any phase of research, excluding clinical trials. The rationale for a research idea may be derived from laboratory discovery, clinical trial results, population-based studies, a clinician’s firsthand knowledge of patients, or anecdotal data. Applications must include preliminary and/or published data that are relevant to MS and the proposed research project. Distinctive Features: This funding mechanism includes two options: Established Investigator or New Investigator. The New Investigator option supports applicants early in their faculty appointments.
Who can apply
- Unrestricted